Autoimmune hemolytic anemia in a patient with myelodysplastic syndrome: Responding to 5-azacitidine therapy.
Jaspreet KaurShahaf TulerConstantin A DasanuPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
Our case indirectly suggests that 5-azacitidine led to a decrease in autoantibody production by the auto-reactive B-cell clone in MDS leading in turn to a diminished rate of autoimmune hemolysis. If our observation is accurate, we believe that similar reports will populate the scientific literature in the future years.
Keyphrases
- acute myeloid leukemia
- multiple sclerosis
- systematic review
- case report
- chronic kidney disease
- current status
- drug induced
- high resolution
- sensitive detection
- fluorescent probe
- living cells
- emergency department
- iron deficiency
- red blood cell
- cell therapy
- mass spectrometry
- quantum dots
- electronic health record
- light emitting